Association between FCGR3B copy number variations and susceptibility to autoimmune diseases: a meta-analysis

Inflammation Research

Volumn 64, Issue 12, 2015, Pages 983-991

  Lee, Young Ho ^a   Bae, Sang Cheol ^b   Seo, Young Ho ^a   Kim, Jae Hoon ^a   Choi, Sung Jae ^a   Ji, Jong Dae ^a   Song, Gwan Gyu ^a  

^a College of Medicine   (South Korea)

^b Hanyang University Hospital for Rheumatic Diseases   (South Korea)

Author keywords

Autoimmune diseases; Copy number variation; FCGR3B; Meta analysis

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIIB; UNCLASSIFIED DRUG; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL EVALUATION; COMPARATIVE STUDY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; EMBASE; ETHNIC GROUP; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HUMAN; MEDLINE; META ANALYSIS; RANDOM ERROR; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS; AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS;

AUTOIMMUNE DISEASES; DNA COPY NUMBER VARIATIONS; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GPI-LINKED PROTEINS; HUMANS; RECEPTORS, IGG;

EID: 84945461721     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-015-0882-1     Document Type: Article

References (45)

1. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med. 2001;7(8):899–905.
2. Becker KG. The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses. 2004;62(2):309–17.
3. Becker KG. Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways? Diabetes. 1999;48(7):1353–8.
4. Li X, Howard TD, Zheng SL, Haselkorn T, Peters SP, Meyers DA, et al. Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol 2010;125(2):328–35 e11.
5. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol. 2001;19:275–90.
6. Su K, Wu J, Edberg JC, McKenzie SE, Kimberly RP. Genomic organization of classical human low-affinity Fcgamma receptor genes. Genes Immun. 2002;3(Suppl 1):S51–6.
7. Choi SJ, Rho YH, Ji JD, Song GG, Lee YH. Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford). 2006;45(2):166–70.
8. Lee YH, Nath SK. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet. 2005;118(3–4):434–43.
9. Brown EE, Edberg JC, Kimberly RP. Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity. 2007;40(8):567–81.
10. Yim S-H, Jung S-H, Chung B, Chung Y-J. Clinical implications of copy number variations in autoimmune disorders. Korean J Intern Med. 2015;30(3):294–304.
11. Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, van der Schoot E, et al. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat. 2009;30(5):E640–50.
12. Mayadas TN, Tsokos GC, Tsuboi N. Mechanisms of immune complex–mediated neutrophil recruitment and tissue injury. Circulation. 2009;120(20):2012–24.
13. Nimmerjahn F, Ravetch JV. Fcγ receptors as regulators of immune responses. Nat Rev Immunol. 2008;8(1):34–47.
14. Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med. 2008;205(7):1573–82.
15. Salmon JE, Pricop L. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum. 2001;44(4):739–50.
16. Chen JY, Wang CM, Chang SW, Cheng CH, Wu YJ, Lin JC, et al. Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients. Arthritis Rheumatol. 2014;66(11):3113–21.
17. Dunstan E, Lester S, Black R, Rischmueller M, Chan H, Hewitt AW, et al. No Association between FC gamma R3B copy number variation and susceptibility to biopsy-proven giant cell arteritis. Arthritis. 2013;2013:514914.
18. Asano K, Matsumoto T, Umeno J, Hirano A, Esaki M, Hosono N, et al. Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis. Inflamm Bowel Dis. 2013;19(10):2061–8.
19. Nossent JC, Rischmueller M, Lester S. Low copy number of the Fc-gamma receptor 3B gene FCGR3B is a risk factor for primary Sjogren’s syndrome. J Rheumatol. 2012;39(11):2142–7.
20. Black R, Lester S, Dunstan E, Shahram F, Nadji A, Bayat N, et al. Fc-gamma receptor 3B copy number variation is not a risk factor for Behcet’s disease. Int J Rheumatol. 2012;2012:167096.
21. Graf SW, Lester S, Nossent JC, Hill CL, Proudman SM, Lee A, et al. Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Res Ther. 2012;14(1):R28.
22. McKinney C, Broen JC, Vonk MC, Beretta L, Hesselstrand R, Hunzelmann N, et al. Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis. Genes Immun. 2012;13(6):458–60.
23. Molokhia M, Fanciulli M, Petretto E, Patrick AL, McKeigue P, Roberts AL, et al. FCGR3B copy number variation is associated with systemic lupus erythematosus risk in Afro-Caribbeans. Rheumatology (Oxford). 2011;50(7):1206–10.
24. Marques RB, Thabet MM, White SJ, Houwing-Duistermaat JJ, Bakker AM, Hendriks GJ, et al. Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis. PLoS One. 2010;5(10):e13173.
25. McKinney C, Fanciulli M, Merriman ME, Phipps-Green A, Alizadeh BZ, Koeleman BP, et al. Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis. 2010;69(9):1711–6.
26. Zhou XJ, Lv JC, Bu DF, Yu L, Yang YR, Zhao J, et al. Copy number variation of FCGR3A rather than FCGR3B and FCGR2B is associated with susceptibility to anti-GBM disease. Int Immunol. 2010;22(1):45–51.
27. Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet. 2007;39(6):721–3.
28. Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet. 2010;19(16):3282–94.
29. Breunis WB, van Mirre E, Bruin M, Geissler J, de Boer M, Peters M, et al. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood. 2008;111(3):1029–38.
30. Mamtani M, Anaya J, He W, Ahuja S. Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun. 2010;11(2):155–60.
31. Yuan J, Zhao D, Wu L, Xu X, Pang Y, Zhang J, et al. FCGR3B copy number loss rather than gain is a risk factor for systemic lupus erythematous and lupus nephritis: a meta-analysis. Int J Rheum Dis. 2015;18(4):392–7.
32. McKinney C, Merriman TR. Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes. Hum Mol Genet. 2012;21(10):2370–6.
33. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep. 2010;37(1):227–34.
34. Lee YH, Bae SC, Choi SJ, Ji JD, Song GG. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep. 2011;38(6):3643–51.
35. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int. 2007;27(9):827–33.
36. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
37. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
38. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
39. Morris DL, Roberts AL, Witherden AS, Tarzi R, Barros P, Whittaker JC, et al. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur J Hum Genet. 2010;18(9):1027–31.
40. Robinson JI, Carr IM, Cooper DL, Rashid LH, Martin SG, Emery P, et al. Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Hum Mutat. 2012;33(4):741–9.
41. Bournazos S, Bournazou I, Murchison JT, Wallace WA, McFarlane P, Hirani N, et al. Copy number variation of FCGR3B is associated with susceptibility to idiopathic pulmonary fibrosis. Respiration. 2011;81(2):142–9.
42. Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Human Mol Genet. 2010;19(16):3282–94.
43. Harper L, Savage C. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol. 2000;190(3):349–59.
44. Ierino F, Powell M, McKenzie I, Hogarth P. Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction. J Exp Med. 1993;178(5):1617–28.
45. Galon J, Paulet P, Galinha A, Lores P, Bonnerot C, Jami J, et al. Soluble Fcγ receptors: interaction with ligands and biological consequences. Int Rev Immunol. 1997;16(1–2):87–111.